🔥Telegram İfşa

Connect with Caris Life Sciences in Orlando during the NRG Oncology Winter meeting. Our experts are ready to chat at Booth 3 about our latest research, current product offerings, and what we have in store for the future of precision medicine. ow.ly/QefT50QAS3x #NRG2024

Unleash the power of liquid biopsy with Caris Assure. This groundbreaking multi-cancer assay offers deep molecular insights from a simple blood sample. Discover how this powerful liquid biopsy assay can transform patient care. ow.ly/Vxvn50QSvoc #precisionmedicine

Sensitivity gap for early detection of precancerous lesions with only 13% detection. Colonoscopy remains the gold standard for CRC screening. “CONCLUSIONS In an average-risk screening population, this cfDNA blood-based test had 83% sensitivity for colorectal cancer, 90%

Wisdom

Great speech by Nayib Bukele!

Eugene Manley, Jr., Ph.D. and Jason Porter starting the II #lungcancer equity summit Daniel Sumarriva #lcsm

📢Highlights from ISLB 2024: Exploring the Future of Liquid Biopsy The 6th Annual Congress of the International Society of Liquid Biopsy (ISLB) in Denver brought together over 300 global experts to discuss the latest innovations in liquid biopsy technology, focusing on its

Caris Life Sciences is proud to announce that it has published more than 1,000 studies across peer-reviewed manuscripts, posters, and abstracts since 2015, in collaboration with its research partners. Learn more: ow.ly/KRj150UtRLQ

MI Cancer Seek™ is now available for clinical ordering. The first and only simultaneous WES/WTS-based assay with CDx indications for adult and pediatric patients. Read more about MI Cancer Seek and view important product information. ow.ly/1bmP50Uy9nN

MI Cancer Seek™ is now available. The first and only simultaneous WES/WTS-based assay with CDx indications for adult and pediatric patients. Read more about MI Cancer Seek and view important product information. ow.ly/8ouu50UEral #precisionmedicine

Caris announces a strategic collaboration with Ontada to drive next-gen therapeutic development and advance cancer care. Learn more: ow.ly/AgFS50UHeLs

MI Cancer Seek™, the first and only simultaneous WES/WTS-based assay with FDA-approved CDx indications for molecular profiling of solid tumors for both adult and pediatric patients. Read more about MI Cancer Seek and view important product information: ow.ly/uIQh50UIzfe

Great collaboration with Amazon Web Services (Amazon Web Services) to accelerate research and enhance patient care through efficient data processing. aws.amazon.com/blogs/hpc/how-…

Grateful for the recent invitation from the SLACOM to present on the Molecular Revolution in Precision Medicine - Daniel Sumarriva @LGCW2024 oncodaily.com/blog/daniel-su… #Medicine #MolecularRevolution #OncoDaily #Oncology #PrecisionMedicine #SLACOM #Cancer #Health #MedX #MedEd

We are publishing EGFR resistant tumor data here after profiling more than 45,000 tumors, the documentation of the prevalence of resistance mutations (718,721,797 etc.) is very important however we need to increase awareness to repeat molecular profiling after TKI failure to have

Outstanding work by Heber Reyes and team on critical disparities in cancer care across Mexico - Daniel Sumarriva Elysse Bautista González oncodaily.com/url/279168 #OncoDaily #Oncology #Cancer #Health #Medicine #CancerCare

Prevalence and molecular correlates of acquired EGFR resistance mutations in NSCLC - Daniel Sumarriva Caris Life Sciences Dr. Luis E. Raez Stephen V Liu, MD Hirva Mamdani Hossein Borghaei, DO Misako Nagasaka oncodaily.com/science/daniel… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc

Enjoying the beautiful view during this special night at the 2025 Giants of Cancer Care awards ceremony! #GiantsCC25 @kalantriShreyas Dr. Dharmik Patel | M.B.B.S | MD Arthur Aung Chinmay Jani Nehemias Guevara-Rodriguez Daniel Sumarriva

Way to Kick Off ASCO 2025 at the Giants of Cancer Dinner - Daniel Sumarriva oncodaily.com/blog/asco-2025… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #ASCO25 #ASCO2025 #GiantsOfCancer CancerWorld

📌15 Posts Not to Miss from the 3rd Day of ASCO 2025 The ASCO Annual Meeting 2025 is officially underway in Chicago! Running from May 30 to June 3, this year’s meeting brings together oncologists, researchers, and advocates worldwide to share the latest breakthroughs in cancer